Target Price Playground
GSK
$47.76
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on GSK? Launch with your exact active legs & +10.0% target.
Forward Projection
If price hits $53 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Own stock + buy put as insurance against downside.
๐ฏ Target
1-Click Institutional Target Anchors:
56d from today
โ๏ธ Legs
LONG 100 SHARES
@ $47.76 ยท ฮ 1.00
LONG PUT ยท $45 ยท Jan '27
Qty 1 ยท Premium $0.97 ยท ฮ -0.27
P&L at Expiry
Stock (100 sh)
Protective Put
Now
Target
๐ก Stock vs Options at Target
If GSK hits $53 by Jan 15: the protective put returns +$381 (7.8%) on $4,873 risked, vs +$478 (10.0%) for 100 shares on $4,776. Options give 0.8ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (56 days out). P&L shown is the value at expiry if GSK is at $53.
๐ Projected Return
P&L if GSK hits $53 by Jan 15
+$381
+7.8% on $4,873 risked
Max Profit
Unlimited
Unlimited upside (minus put cost)
Max Loss
โ$373
Put floors you at $45
Break-even
$48.73
+2.03% from spot
Prob. of Profit at Expiry (PoP)
43.2%
Above breakeven ($48.73)
ยท Touch Target: 39%
30-Day Theta Burn (If Flat)
โ$44
0.9% of entry cost ยท Daily ฮ: $-1.48/day
Net ฮ / ฮ / V
73.37 / -1.48 / 6.14
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| GSK Price | Today | +3d (Nov 23) | +7d (Nov 27) | Dec 8 | Dec 27 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $38 (-20%) | -$383 | -$384 | -$385 | -$386 | -$383 | -$373 |
| $41 (-15%) | -$345 | -$348 | -$351 | -$360 | -$374 | -$373 |
| $43 (-10%) | -$273 | -$277 | -$283 | -$300 | -$336 | -$373 |
| $45 (-5%) | -$157 | -$162 | -$169 | -$189 | -$235 | -$336 |
| $47 (-2%) | -$68 | -$72 | -$79 | -$99 | -$141 | -$193 |
| $48 (0%) โ spot | +$0 | -$4 | -$11 | -$29 | -$65 | -$97 |
| $49 (+2%) | +$73 | +$69 | +$63 | +$47 | +$17 | -$1 |
| $50 (+5%) | +$190 | +$187 | +$182 | +$170 | +$149 | +$142 |
| $53 (+10%) โ target | +$403 | +$401 | +$398 | +$391 | +$382 | +$381 |
| $55 (+15%) | +$628 | +$627 | +$626 | +$622 | +$619 | +$619 |
| $57 (+20%) | +$862 | +$861 | +$860 | +$859 | +$858 | +$858 |
Uses GSK's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.